Benitec Biopharma grants 356,900 options to CEO and 153,000 to Exec Director at $0.23/share

Benitec Biopharma Inc.

CEO Dr. Jerel Banks granted nonqualified stock options for 356,900 shares at $0.23 per share.
Executive Director Megan Boston granted nonqualified stock options for 153,000 shares at $0.23 per share.
Options vest in three equal annual installments, subject to continued service through each vesting date.
Unvested options fully accelerate upon a Change in Control as defined in the 2020 Equity Plan.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.